<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
Blogs

Pharmacy News and Stories

By Author

Lauren Wise


Alumni

Recent PhD graduate puts it all together with research

Six graduates were recently conferred their degrees from the CU Skaggs School of Pharmacy and Pharmaceutical Sciences through the CU Anschutz Graduate Program during the fall 2020 Commencement, Saturday, Dec 12. Philanthropic Advisor Lauren Wise had a chance to speak with one of the graduates, Reena Berman, about her experience pursuing her PhD in Toxicology. Here’s how Reena responded to the questions:


Author Lauren Wise | Publish Date December 19, 2020
Full Story

Alumni

"CU has given me everything that I have in the US.”

Lauren Wise with the Advancement Office recently had a conversation with 2019 CU Pharmacy alumnus Stefanos Aivazidis, who spoke on his time at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, pursuing his PhD in Toxicology. Below is the discussion between the two:


Author Lauren Wise | Publish Date November 21, 2020
Full Story

School of Pharmacy In the News

Medscape

Medical Cannabis for Chronic Pain Tied to Arrhythmia Risk

news outletMedscape
Publish DateFebruary 13, 2024

Adults using medical cannabis for chronic pain, especially those with cancer or cardiometabolic disease, have a slightly elevated risk of developing arrhythmia, according to an editorial by Robert Page, PharmD

Full Story
KDVR

Colorado company developing potential prescription psilocybin product

news outletKDVR
Publish DateJanuary 17, 2024

Dr. David Kroll, PhD, says right now psilocybin is listed as a schedule one drug with no medical benefit and a high potential for abuse. “So, it is a risky proposition for these companies," he said, "but the clinical trials that have come out to date have been so promising that these companies have been able to acquire investors."

Full Story
The Denver Post

Littleton company developing psilocybin microdosing drug in hopes of FDA approval

news outletThe Denver Post
Publish DateJanuary 09, 2024

Though they hope to gain FDA approval soon, it may take some time. Dr. David Kroll, PhD, said the company will have additional hurdles to clear with the agency. 

Full Story
Neurology Today

Neurology Drugs Are Getting Better—and More Expensive—With More Prior Authorization Hassles

news outletNeurology Today
Publish DateJanuary 04, 2024

“The payers are trying to squeeze wherever they can,” said Dr. Kavita Nair, PhD, FAAN, a neurology professor and pharmacy outcomes researcher at the University of Colorado and vice chair of the American Academy of Neurology's Coding and Payment Policy Subcommittee.

Full Story